Member
Details of Support
The National Cancer Center Kashiwa Campus (East Hospital, Exploratory Oncology Research & Clinical Trial Center, and Center for Promotion of Translational Research supports the discovery and development of seeds based on basic research results and clinical needs, with the aim of developing them from non-clinical to clinical trials. The National Cancer Center promotes the practical application of seeds in collaboration with academia and venture companies inside and outside the National Cancer Center. In recent years, there has been a demand for multifaceted drug development, including antibody drugs and genome analysis technologies, and the National Cancer Center provides opportunities for researchers and companies to meet powerful partners through open innovation.
-
through the aggregation of advanced expertise.
Seed Discovery and Nurturing -
Diverse Collaborations
-
High-quality clinical research
Details of Support
The Teijin Group is engaged in the development of regenerative and cell medicine products and contract drug development and manufacturing (CDMO) business through its group companies, TEIJIN REGENET and J-TEC. Both companies provide process development and manufacturing support specialized for regenerative and cell medicine products to support the creation of innovative medical treatments. We provide one-stop support for everything from research and development of regenerative medicine products to the manufacture of investigational drugs and commercial production, based on the know-how of J-TEC, a leader in regenerative medicine, and our three bases: the Kashiwa-no-ha Facility (Kashiwa City, Chiba Prefecture), the Iwakuni Factory (Iwakuni City, Yamaguchi Prefecture), and J-TEC (Gamagori City, Aichi Prefecture). In addition, through alliances with companies in Taiwan and the U.S., we are able to supply viral vectors and expand overseas utilizing our global manufacturing infrastructure.
-
One-Stop Solutions
for Cell Production -
Track record of pharmaceutical approval for 5 regenerative medicine products
-
Vector manufacturing and
Providing support for overseas clinical trials
Details of Support
Based on our experience in developing regenerative medical products such as autologous cultured epidermis, autologous cultured cartilage, and autologous cultured corneal epithelium, we provide total support for the development of regenerative medical products. Specifically, we provide technical support for the development and manufacture of products using advanced culture techniques and quality control support for the provision of high-quality, safe products.
-
Leader in regenerative medicine
-
reliability
-
Autologous cell platformer
Details of Support
Mitsui Fudosan is supporting the creation of innovation in the life science field by providing facilities such as the Mitsui Link-Lab, a rental lab and office, and working with LINK-J, a general incorporated association, to create an ecosystem in which startups, universities, research institutes, and major pharmaceutical companies can cooperate. In Kashiwa-no-ha Smart City, public, private and academic sectors are working together to develop business activities with the aim of realizing an area where people can live a lifespan of good health and where new medical industries can be born and nurtured.
-
Community Management
-
Strengthening Cooperation
-
communicativity